Q1 FY2027 · ended Sep 30, 2026 · Revenue $264.76M, +12.1% YoY · Filed Nov 3, 2026
InnovAge Holding Corp. (INNV) files with the SEC under industry code 8000, Services-Health Services. In Q1 of fiscal 2027, the quarter ended Sep 30, 2026, it reported revenue of $264.8 million and net income of $19.6 million. Free cash flow was $25.8 million. As of Sep 30, 2026 it held $163.0 million in cash and investments and $83.9 million in total debt.
Revenue
$264.76M
+12.1% vs year-ago quarter
Net income
$19.55M
+143.8% vs year-ago quarter
Operating cash flow
$28.74M
+632.5% vs year-ago quarter
Free cash flow
$25.75M
+16932.7% vs year-ago quarter
EPS
$0.14
+133.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
136.46M
+0.6% vs year-ago quarter
Net cash
$79.06M
Q1 FY2027
Operating margin
1.4%
TTM
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- INNV (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Denver, CO
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1834376
- Former names
- TCO GROUP HOLDINGS, INC. (until Jan 20, 2021)
Other Services-Health Services companies
- LifeStance Health Group, Inc. LFST
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- Pennant Group, Inc. PNTG
- U S Physical Therapy Inc /NV USPH
- Omada Health, Inc. OMDA
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Sep 30, 2026 |
Q4 FY2026 Jun 30, 2026 |
Q3 FY2026 Mar 31, 2026 |
Q2 FY2026 Dec 31, 2025 |
Q1 FY2026 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $264.8M | $262.0M | $251.9M | $239.7M | $236.1M |
| Operating income | $20.1M | $10.1M | -$29.1M | $13.3M | $8.3M |
| Net income | $19.6M | $8.3M | -$29.5M | $10.6M | $8.0M |
| Diluted EPS | $0.14 | $0.06 | -$0.22 | $0.08 | $0.06 |
| Operating cash flow | $28.7M | $21.3M | $18.1M | $21.4M | $3.9M |
| Free cash flow | $25.8M | $17.0M | $14.5M | $19.0M | -$153,000 |
| Total assets | $563.0M | $557.4M | $547.4M | $527.5M | $510.2M |
| Total liabilities | $273.7M | $288.6M | $288.5M | $238.7M | $234.5M |
| Stockholders' equity | $255.3M | $235.6M | $229.0M | $256.8M | $245.0M |
| Cash and investments | $163.0M | $141.3M | $138.6M | $126.0M | $109.4M |
| Total debt | $83.9M | $87.7M | $93.8M | $95.4M | $98.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| ARS | Annual report to shareholders | Oct 22, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Sep 24, 2026 | Sep 22, 2026 |
| 10-K | Annual report | Sep 9, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 8, 2026 | Sep 8, 2026 |
All 271 InnovAge Holding Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.